Benzinga's Top #PreMarket Losers

By: via Benzinga
NPS Pharmaceuticals (NASDAQ: NPSP) fell 10.70% to $29.20 in pre-market trading. The FDA has voted 8-5 in favor of NPS Pharmaceuticals' ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.